Estradiol/norethisterone transdermal - Rottapharm

Drug Profile

Estradiol/norethisterone transdermal - Rottapharm

Alternative Names: Combestril; Estrogen/progestin combined matrix patch

Latest Information Update: 12 Mar 2010

Price : $50

At a glance

  • Originator Rottapharm
  • Class Estradiol congeners; Estrenes; Hormonal contraceptives; Hormonal replacements; Norpregnenes; Oral contraceptives; Small molecules
  • Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Menopausal syndrome

Most Recent Events

  • 23 Mar 2007 Preregistration for Menopausal syndrome in European Union (Transdermal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top